AVIR Market Cap & Key Metrics
Atea Pharmaceuticals, Inc.
$4.73
+$0.10(+2.16%)
38
Overall
60
Value
20
Tech
34
Quality
Market Cap
$371.35M
Volume
31.04K
52W Range
$2.87 - $6.45
Target Price
$8.50
AVIR market cap is $371.35M. This page lists Atea Pharmaceuticals, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
AVIR Key Metrics
- Market cap
- $371.35M
- EPS estimate, current year
- $-1.99
- EPS growth, 3-year
- -11.75%
- Value score
- 60
- Quality score
- 34
- Technical score
- 20
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | $351.37M |
| EBITDA | -$164.09M | -$167.04M | -$134.52M | -$130.39M | $138.41M |
| EPS | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.46 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVIR | $4.73 | +2.2% | 31.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atea Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW